Hyundai Bioscience Co., Ltd. (KOSDAQ:048410)

Hyundai Bioscience Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	3,657	1,812	2,732	9,189	19,215
Short-Term Investments	-	10,000	16,000	13,010	-
Cash & Short-Term Investments	3,657	11,812	18,732	22,199	19,215
Cash Growth	-69.04%	-36.94%	-15.62%	15.53%	172.36%
Accounts Receivable	247.21	446.21	1,277	7,628	11,035
Other Receivables	85.09	19.54	50.97	55.15	2,414
Receivables	332.3	465.75	1,671	8,825	17,250
Inventory	1,076	2,588	2,946	3,350	4,215
Prepaid Expenses	381.52	204.45	568.66	337.92	195
Other Current Assets	1,364	92.36	93.33	138.65	985
Total Current Assets	6,810	15,163	24,012	34,851	41,860
Property, Plant & Equipment	3,583	2,904	6,376	6,073	6,674
Long-Term Investments	22,732	1,593	1,469	4,930	4,875
Other Intangible Assets	33,170	31,170	33,175	33,664	39,395
Other Long-Term Assets	498.05	914.36	1,268	929.34	877.22
Total Assets	67,705	52,792	67,327	80,528	93,741
Accounts Payable	555.33	430.52	686.72	191.61	178.17
Accrued Expenses	137.19	141.71	141.35	123.66	143.59
Short-Term Debt	25,832	5,400	5,900	14,014	6,400
Current Portion of Long-Term Debt	-	-	111.08	833.32	833.36
Current Portion of Leases	440.49	114.1	196.17	354.1	369.82
Other Current Liabilities	521.41	860.43	1,957	1,744	1,652
Total Current Liabilities	27,487	6,947	8,992	17,261	9,577
Long-Term Debt	-	-	-	111.08	29,112
Long-Term Leases	320.53	32.43	41.7	174.69	423.22
Long-Term Deferred Tax Liabilities	-	-	-	1,296	2,073
Other Long-Term Liabilities	459.04	541.56	57.23	57.23	15
Total Liabilities	28,266	7,521	9,091	18,957	41,403
Common Stock	19,911	19,905	19,841	19,330	17,958
Additional Paid-In Capital	39,806	38,827	145,476	133,406	104,930
Retained Earnings	-19,741	-12,812	-106,288	-90,481	-70,430
Treasury Stock	-4.04	-4.04	-4.04	-4.04	-4.04
Comprehensive Income & Other	-532.99	-645.72	-789.52	-680.57	-116.86
Shareholders' Equity	39,438	45,271	58,235	61,571	52,338
Total Liabilities & Equity	67,705	52,792	67,327	80,528	93,741
Total Debt	26,593	5,547	6,249	15,488	37,138
Net Cash (Debt)	-22,937	6,265	12,483	6,712	-17,923
Net Cash Growth	-	-49.81%	86.00%	-	-
Net Cash Per Share	-575.94	157.72	317.10	181.81	-499.06
Filing Date Shares Outstanding	39.82	39.81	39.68	38.66	35.91
Total Common Shares Outstanding	39.82	39.81	39.68	38.66	35.91
Working Capital	-20,677	8,216	15,020	17,590	32,283
Book Value Per Share	990.43	1137.24	1467.61	1592.73	1457.32
Tangible Book Value	6,269	14,101	25,061	27,906	12,943
Tangible Book Value Per Share	157.42	354.23	631.56	721.89	360.39
Land	1,100	1,100	1,100	1,100	1,100
Buildings	3,834	3,834	5,190	5,190	5,190
Machinery	10,435	10,435	11,644	13,822	13,822
Construction In Progress	980.27	16	773.4	225	-

Updated Mar 17, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.